Enhance your World Congress experience by participating in innovative sessions designed to provide unique perspectives and professional development. When indicated, registration is available through the World Congress registration process.
Breaking Through The Clutter: A Primer on Communicating Science and Health to the Public
Wednesday, September 12, 2018; 9:00-11:00 a.m. or 1:00-3:00 p.m.
Registration Price: $20
This two-hour session with seasoned communications experts and media trainers will provide attendees with the skills they need to engage effectively with non-scientific audiences. You will learn how to speak with brevity and maintain accuracy using messages and storytelling, and share tools to make sure you feel in control when meeting with journalists, funders, policymakers or the public. The session is highly interactive with video examples and exercises. Registration is required and spaces are limited and going fast. This exclusive opportunity is supported by a grant from The Mayday Fund.
Pain Management in Elite Athletes
Thursday, September 13, and Saturday, September 15; 12:00-2:00 p.m. (lunch will not be served)
Pain is common among elite athletes and is frequently associated with sport injury. Because no evidence-based or consensus-based guidelines existed to manage pain in elite athletes, the International Olympic Committee (IOC) convened a panel of experts in November 2016 to evaluate the state of the science and practice of pain management. This two-part session will present salient findings of the IOC consensus document, (2) provide an overview of policy from major sports organizations, and (3) present illustrative case discussions. The multidisciplinary panel of speakers represent physicians and clinicians with backgrounds in neurology, pain medicine, anesthesiology, neurosurgery, and physical therapy, plus former elite athletes.
Faculty for Part I: Findings of the International Olympic Committee
Wayne Derman, MD
Director, Institute of Sport and Exercise Medicine
Co-Director, International Olympic Committee Research Center
Director, FIFA Medical Center of Excellence
Stellenbosch University, Division of Orthopedic Surgery
Brian Hainline, MD
Chief Medical Officer, National Collegiate Athletics Association
Clinical Professor of Neurology, Indiana University School of Medicine and New York University School of Medicine
Stan Herring, MD
Medical Director, University of Washington Medicine Sports, Spine and Orthopedic Health
Clinical Professor, University of Washington Rehabilitation Medicine, Orthopedics and Sports Medicine, and Neurological Surgery
Johan Raeder, MD
Professor of Anesthesiology, University of Oslo; University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Allen Sills, MD
NFL Chief Medical Officer
Professor of Neurological Surgery
Orthopaedic Surgery and Rehabilitation, Vanderbilt University
Part 2: Case Reports of Elite Athletes in Pain
Cheri Blauwet, MD
Chair, International Paralympic Committee Medical Committee
Board of Directors, U.S. Anti-Doping Agency
Attending Physician, Brigham and Women’s Hospital/Spaulding Rehabilitation Hospital
Assistant Professor of Physical Medicine and Rehabilitation, Harvard Medical School
Formerly with the Miami Dolphins and Indianapolis Colts, now Vice President of Wellness and Clinical Services for the NFL
Former professional tennis player, (No. 4 in the world)
Maleeva Tennis Club, Sofia, Bulgaria
Allen Sills, MD
Chief Medical Officer, National Football League
Professor of Neurological Surgery, Orthopedic Surgery and Rehabilitation, Vanderbilt University
Kathleen Stroia, MS, ATC, PT
Senior Vice President, Sport Sciences & Medicine and Transitions, World Tennis Association Tour
Guiding Pain and Interprofessional Education Through Competencies
Friday, September 14, 2018; 12:30-2:00 p.m.
Registration Price: $20 (includes lunch)
Organized By the 2018 Global Year Task Force
This session will review recent developments in advancing pain education through use of competencies for pain in uni- and interprofessional curricula. These will include mapping of competencies against overarching profession-specific competencies, novel education programs and curricula across professions and stages of practice, and aspirational goals for how competencies can improve pain education around the world. Practical strategies and examples will be discussed of how best to integrate pain competency in individual programs, systems and policy level education. Participants will have the opportunity to interact with colleagues to share best practices and brainstorm new ideas.
Scott M. Fishman, MD
Fullerton Endowed Chair in Pain Medicine
Professor of Anesthesiology and Pain Medicine
Professor of Psychiatry and Behavioral Sciences (secondary)
Chief, Division of Pain MedicineVice Chair, Department of Anesthesiology and Pain Medicine
Director, Center for Advancing Pain Relief
University of California, Davis School of Medicine
Judy Watt-Watson, RN MSc PhD
Lawrence S. Bloomberg Faculty of Nursing
Senior Fellow, Massey College
Executive Member, Centre for the Study of Pain
University of Toronto
Pain Neuroimaging Night at the A.A. Martinos Center for Biomedical Imaging
Friday, September 14; 6:00 PM – 9:00 p.m.
Registration Price: $50 (roundtrip transportation from the BCEC and refreshments will be provided)
Hosted by: A.A. Martinos Center for Biomedical Imaging, IASP and the Center for Integrative Pain Neuroimaging (CiPNI)
Limited capacity – Register early!
Note: Once you have entered the registration site, you will be taken to your Dashboard, from there you may select the Add Sessions & Events button where you may click through the various pages of offerings. You will find the Martinos Center event on the Special Sessions page (4th page in the series).
The Athinoula A. Martinos Center for Biomedical Imaging is part of the Department of Radiology at Massachusetts General Hospital, Harvard Medical School. It is one of the world’s largest and most comprehensive academic biomedical imaging research enterprises, with over 150 investigators, 8 human MRI scanners, combined PET/MR, M/EEG, Optical Imaging, and ultrahigh field MRI facilities for small animal imaging.
The Martinos Center is one of the birthplaces of functional MRI (fMRI), and continues to be a resource for novel pain neuroimaging discoveries. Many of the imaging equipment is from Siemens Healthineers and delegates will be able to tour the facilities and view the latest in imaging technology. The following areas of the center will be toured:
Station 1: Magnetoencephalography (MEG) and Electroencephalography (EEG)
Station 2: Positron emission tomography (PET)
Station 3: 3T, 7T and 9.4T Magnetic resonance imaging (MRI)
Station 4: Large-bore MRI Systems Bays 1, 3 3T MRI Trio 1, 2, 3 and 3T Skyra
Station 5: Connectome Imaging at LF-MRI Building 75 setups as well as a triggering interface.
Station 6: Functional near-infrared spectroscopy (fNIRS) at Optics Division
5:30-5:40 p.m. Buses depart BCEC northeast level one (vestibule door across from meeting room 156)
6:00-6:15 p.m. Buses arrive from BCEC
6:15-6:30 p.m. Welcome by Center Director, Bruce Rosen MD, PhD
6:30-7:15 p.m. Refreshments served; tours begin
7:15-9:00 p.m. Full tour and overview of the facility
9:00-9:15 p.m. Buses return to BCEC
Detailed information regarding the stations at Martinos Center:
The Pain Imaging Tour of the latest imaging technology used in research and clinical use will provide participants with a clear understanding of new innovations available to them and their uses.
The key strategies are:
- To increase the knowledge of participants on imaging technologies: clinicians and researchers working in the field of pain management.
- Increase participant knowledge and skills in state-of-the-art devices for use in pain management for acute, chronic and cancer pain.
- To share relevant research with peer and discuss with experts working at the center.
The learning objectives upon completion of this activity are that participants will able to:
- Enhance their skills and knowledge on imaging in pain management for acute, chronic and cancer pain.
- Discuss the latest and current research and developments in these areas.
- Translate learning experiences into their clinical practice.
Each station will have a general demonstration and discussion on the specific imaging equipment and their uses and applications to pain neuroimaging. An overall description of the technology presented at each station is outlined below:
STATION 1: Magnetoencephalography (MEG) and Electroencephalography (EEG)
Magnetoencephalography (MEG) is a noninvasive technique used to measure magnetic fields generated by small intracellular electrical currents in neurons of the brain. In this way MEG can provide direct information about the dynamics of evoked and spontaneous neural activity and the location of their sources in the brain. MEG and EEG are closely related, the latter detecting the electric potentials generated by neural currents instead of the corresponding magnetic fields. However, it turns out that the task of inferring the sites of brain activation is often more straightforward with MEG than with EEG. This is due to the electric and magnetic properties of the tissues in the cranium as well as to the fact that MEG is selectively sensitive to currents flowing tangential to the scalp, corresponding to sulcal activations. In contrast, the interpretation of EEG is often complicated by the simultaneous presense of both sulcal and gyral sources, the latter corresponding to radial currents.
Clinically, MEG is used to detect and localize epileptiform spiking activity in patients with epilepsy. Also, when planning for removal of brain tumors, surgeons will use it to localize brain areas important for speech that should be avoided.
At the Martinos Center, researchers use MEG – often in conjunction with EEG, MRI, fMRI and optical imaging – to obtain maps of brain activity in cognitive neuroscience studies carefully designed to investigate the workings of the normal and damaged brain.
STATION 2: Positron emission tomography (PET)
Positron emission tomography (PET) is a noninvasive imaging method used to obtain quantitative molecular and biochemical information about physiological processes in the body. PET imaging can show the chemical functioning of organs and tissues in the living object. PET can help to advance a range of applications. It can be a powerful tool in drug discovery and development, for example, as it can noninvasively assess drug distribution and action at the molecular level. Preliminary studies indicate that dynamic PET imaging – using repeated images over time – can be a valuable technique for defining the time course of uptake and retention of radiolabeled anticancer drugs in tumors and in the surrounding normal tissue in patients. These drugs are designed to inhibit key processes in cancer initiation and progression: angiogenesis, proliferation, avoidance of cell death or apoptosis, invasion and metastasis, and transduction of signals that modulate these processes. In the clinical environment PET has established its efficacy in cancer studies, though these studies have only begun to utilize the full potential of PET imaging
STATION 3: 3T, 7T and 9.4T Magnetic resonance imaging (MRI)
Bay 4: 3T MRI
This is a 3T Siemens Prisma fit. The system features the Siemens XR200 gradient system. Bay 4 is equipped with a full assortment of body imaging coils as well as Siemens 32-channel and 64-channel head-neck coils. Bay 4 is also multi-nuclear capable and an MGH-built 8-channel 31P head array is available. In addition, it contains an assortment of audio, visual, and sensory stimulus equipment for fMRI studies including rear projection, audio stimulation, a subject response device, and an eye tracking setup. Bay 4 has also been configured to allow simultaneous TMS stimulation as well as recording of simultaneous EEG.
Bay 5: 7T MRI Laboratory
This laboratory supports an ultrahigh-field 7 Tesla whole-body MRI. The 7T whole body magnet (90 cm magnet ID) was built by Magnex Scientific (Oxford, UK). Siemens provided the conventional MRI console, the gradient and gradient drivers, and the patient table. The system has been upgraded by Siemens to contain 8 independent 1kW transmit channels capable of simultaneous parallel excitation with different RF pulse shapes for B1 shimming and/or parallel transmit methods such as transmit SENSE. The 7T scanner environment includes a visual display system and a button box for acquiring subject responses in the scanner. A MedRad power injector is installed in the Bay for the injection of gadolinium contrast agents.
Bay 9: Small-bore MRI Systems – 9.4T Laboratory
The 9.4T (400 MHz proton frequency) 21-cm diameter horizontal bore magnet (Magnex Scientific) uses a Bruker Avance console, and is capable of multinuclear imaging and spectroscopy of small animals (rats and mice). Capabilities include high-quality high-resolution anatomical and functional imaging, using a wide variety of contrast mechanisms (T1, T2, diffusion, perfusion), together with multi-shot 2D and 3D sequences, single shot EPI, localized spectroscopy and spectroscopic imaging. The dual gradient system comprises a Bruker gradient coil capable of 44 G/cm, and a Resonance Research (Billerica, MA) gradient insert capable of 150 G/cm.
STATION 4: Large-bore MRI Systems Bays 1, 3 3T MRI Trio 1, 2, 3 and 3T Skyra
Bay 3: 3T MRI 1
This is a 32-channel Siemens Tim Trio 3T whole-body MRI scanner. The whole-body gradient system uses the same gradients as the 1.5T Avanto (45 mT/m strength, 200T/m/s slew rate). It has 32 independent RF receive channels for phased array coils, including a Siemens 32-channel head coil and a home-built 32-channel head coil for the gradient insert. Bay 3 further features an insertable asymmetric head gradient coil (Siemens AC88) that is capable of 60 mT/m and slew rates in excess of 600 T/m/s at a duty cycle of 70%, allowing single-shot 3mm resolution EPI with an echo spacing of 300 µs at a sustained rate of 14 images/second. Bay 3 also contains an assortment of audio, visual, and sensory stimulus equipment for fMRI studies including rear projection, audio stimulation, a subject response device, and an eye tracking setup.
Bay 1: Siemens 3T Skyra
This is a Siemens 3T Skyra with 128-channel receive capabilities and 2-channel parallel transmit. The system comes with 128 RF channels, 40mT/m gradients and a 70cm patient bore for improved subject comfort (and mandatory for fetal imaging) and stimulus access. The scanner provides Siemens 32- and 64-channel head coils as well as an assortment of body arrays. Bay 1 also contains an assortment of audio, visual, and sensory stimuli equipment for fMRI studies, including digital high-definition rear projection, audio stimulation, and a subject response device. The stimulus equipment is set up to be run from a PC, a Macintosh, or the user’s laptop computer. Stimuli can trigger or be triggered by the scanner. Bay 1 is also equipped with a state-of-the-art power injector. Furthermore, the system is configured for simultaneous TMS/MRI operation, including a video navigation system for the TMS stimulator.
STATION 5: Connectome Imaging at LF-MRI Building 75
Bay 8: 3T Laboratory
Connectome imaging techniques provide the opportunity of mapping the human brain pathways in vivo at unprecedented resolution.
Siemens Skyra 3T platform is the “Connectome” scanner, which is based on a Siemens Skyra 3T with the 300mT/m SR=200T/m/s “connectome” gradients. The full gradient strength is available for maximum duty-cycle on diffusion images. Since the diffusion pulses and EPI readout have different needs (diffusion pulses need high Gmax and modest slew rate while EPI needs only a ~50mT/m at 200T/m/s slew rate), the combination of 300mT/m and SR=200T/m/s is potent and usable for diffusion imaging without peripheral nerve stimulation. This gradient strength is useful for achieving high b value diffusion imaging in a short echo time (TE). For example, a b =15,000s/mm2 diffusion weighting can be acquired with a TE of about 55ms, compared to 120ms for a conventional 40mT/m scanner. This improves the diffusion images in two ways: First, it shortens the diffusion time and thus reduces blurring of the water PDF. Second, it increases SNR by about 3.5 fold by reducing loss to T2 decay. The system comes with 64 RF channels and a home-built 32- and 64-channel brain arrays available. The bore is reduced to 56 cm to accommodate the bigger gradients and the gradients have a linear region (to 5%) of 20 cm. Bay 8 also contains visual (rear projection) and auditory stimulation setups as well as a triggering interface.
STATION 6: Functional near-infrared spectroscopy (fNIRS) at Optics Division
Near Infrared Spectroscopy and Diffuse Optical Tomography
Using fNIRS, brain activity is measured through hemodynamic responses associated with neuronal activity. The use of fNIRS as a functional imaging method relies on the principle of neuro-vascular coupling also known as the haemodynamic response or blood-oxygen-level dependent (BOLD) response. This principle also forms the core of fMRI techniques. fNIRS includes the use of diffuse optical tomography (DOT/NIRDOT) for functional assessment. Multiplexing fNIRS channels can allow 2D topographic functional maps of brain activity while using multiple emitter spacings, and may be used to build 3D tomographic maps.
The Optics division offers two CW-DOT imaging systems (CW6), each with 32 lasers and 32 detectors (manufactured by TechEn) and One CW-DOT (CW5) + multiplexer with 26 continuous lasers and 6 lasers multiplexed to 200 output fibers, Three supplemental source extensions boxes for CW6 systems, each with 32 lasers, One frequency-domain 2 wavelength spectrometer, 40 switched output fibers, 8 APD detectors and two CW-NIRS systems, each with 16 lasers and 8 detectors (manufactured by TechEn). There is also three ISS frequency domain systems, one with 32 laser diodes and 4 photomultiplier detectors (Imagent™ functional brain imaging), two with 16 laser diodes and 2 photomultiplier detectors (OxiTS), a time-domain diffuse optical tomography (TD-DOT) imaging system, with an image intensified CCD detector and optically multiplexed sources, a time-domain fluorescence diffuse optical tomography (TD-DOT) imaging system, with an image intensified CCD detector and motorized source positioning system and a 3D camera system for surface acquisition for small animal optical tomography (Technest Holdings Inc.,). A supercontinuum laser system consisting of Photonic Crystal Fiber (PCF, NL-PM-750, Thorlabs) fiber coupling system consisting of a 2 axis translation stages to hold an aspheric lens and PCF (Newport) Electrostrictive actuators (AD-100, Newport) and controller for precision micrometer positioning. Two diffuse correlation spectroscopy systems with 785 nm diode pumped solid state lasers, 4 photon counting APD detectors and 256-tau 8 channel correlators.
Advocating for Pain Relief Worldwide: Best Practices from Around the Globe
Saturday, September 15, 2018; 90 minutes 12 noon – 1:30 p.m.
Part 1: IASP Advocacy Efforts and Update on ICD-11
This session will provide (1) an overview of IASP advocacy efforts with the WHO and summarize the status of ICD-11 initiative with the WHO and globally; (2) offer perspectives from the Association of South-East Asian Pain Societies (ASEAPS), recounting its regional work and creation of a Pain Clinic Tool Kit; and (3) summarize the work of the U.S. National Pain Strategy, showcasing the collaborative efforts of the American Pain Society and other groups.
Mary Cardosa, MBBS
ASEAPS Representative and Chair, Pain Clinical Tool Kit Organizing Group
William Maixner, DDS, PhD
President, American Pain Society
Member, Interagency Pain Research Coordinating Committee (IPRCC), National Institutes of Health
Rolf-Detlef Treede, Prof., Dr. Med.
IASP Immediate Past President
Chair, IASP ICD-11 Task Force
IASP Liaison to the World Health Organization
Part 2: Introducing the Societal Impact of Pain: A Case of Successful Collaborative Advocacy for Pain in Europe
This session will (1) introduce the Societal Impact of Pain (SIP) platform as Europe’s leading advocacy vehicle for improved pain policy, (2) explain the methodology behind SIP and ways it could apply to other regions, and (3) reflect upon the International Classification of Diseases (ICD) as a key policy lever used by SIP.
Member of the European Parliament
Alliance of Liberals and Democrats for Europe, Ireland
Bart Morlion, MD, PhD
President of the European Pain Federation, EFIC
Thomas Tölle, Prof., Dr. Med.
Chair of the Advocacy Committee of the European Pain Federation, EFIC and member at-large of the European Pain Federation Executive Board
Innovative Teaching and Assessment Strategies for the Pain Educator
Saturday, September 15, 2018; 12:30-2:00 p.m.
Registration Price: $20 (includes lunch)
Organized By the 2018 Global Year Task Force
This session will focus on identifying and developing innovative and timely teaching and assessment strategies in pain education. The topics will look towards a global embrace of pain education with: high-impact conversations, patient-centered treatment plans, distance learning, and creative technologies all designed to advance meaningful competency in interprofessional pain care. Following an introduction to set the stage addressing diverse teaching methodologies and updates in assessment of pain education, participants will divide into facilitated small groups working with education leaders to create innovative learning activities and develop assessment techniques.
Beth B. Hogans, M.S. (Biomath), M.D., Ph.D.
Director of Pain Education
Department of Neurology
Johns Hopkins School of Medicine
Antje M. Barreveld, MD
Assistant Professor of Anesthesiology, Tufts University School of Medicine
Co-Principal Investigator, HSDM-BWH NIH Pain Consortium Center of Excellence in Pain Education
Medical Director, Pain Management Center
Director, Substance Use Services (SUS)
Anesthesiologist, Commonwealth Anesthesia Associates (CAA)